Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

Total article views   Abstract views HTML views PDF downloads Totals
9,717 Dovepress* 6,422 1,029+ 961 7,451
PubMed Central* 0 2,266 349 2,266
Totals 6,422 3,295 1,310 9,717
*Since 12 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar